Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Methods Mol Biol ; 1403: 603-22, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27076156

RESUMEN

Transfection technology is an important tool in the investigation of gene function and the modulation of gene expression, thereby contributing to the advancement of basic cellular research, drug discovery, and target validation. Creation of the mutant cells through gene disruption and exogenous protein expression with noticeable phenotype like reporter genes are among other key applications. In this chapter, protocols for generating recombinant Leishmania expressing EGFP or EGFP-Luciferase and their applications are given in detail.


Asunto(s)
Genoma de Protozoos/genética , Leishmania/genética , Leishmania/inmunología , Vacunas Antiprotozoos/inmunología , Transfección/métodos , Animales , Clonación Molecular , Evaluación Preclínica de Medicamentos , Genotipo , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Luciferasas/genética , Luciferasas/metabolismo , Ratones , Imagen Óptica
2.
Korean J Parasitol ; 53(4): 385-94, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26323836

RESUMEN

Leishmaniasis is a worldwide uncontrolled parasitic disease due to the lack of effective drug and vaccine. To speed up effective drug development, we need powerful methods to rapidly assess drug effectiveness against the intracellular form of Leishmania in high throughput assays. Reporter gene technology has proven to be an excellent tool for drug screening in vitro. The effects of reporter proteins on parasite infectivity should be identified both in vitro and in vivo. In this research, we initially compared the infectivity rate of recombinant Leishmania major expressing stably enhanced green fluorescent protein (EGFP) alone or EGFP-luciferase (EGFP-LUC) with the wild-type strain. Next, we evaluated the sensitivity of these parasites to amphotericin B (AmB) as a standard drug in 2 parasitic phases, promastigote and amastigote. This comparison was made by MTT and nitric oxide (NO) assay and by quantifying the specific signals derived from reporter genes like EGFP intensity and luciferase activity. To study the amastigote form, both B10R and THP-1 macrophage cell lines were infected in the stationary phase and were exposed to AmB at different time points. Our results clearly revealed that the 3 parasite lines had similar in vitro infectivity rates with comparable parasite-induced levels of NO following interferon-γ/lipopolysaccharide induction. Based on our results we proposed the more reporter gene, the faster and more sensitive evaluation of the drug efficiency.


Asunto(s)
Anfotericina B/farmacología , Antiprotozoarios/farmacología , Evaluación Preclínica de Medicamentos/métodos , Proteínas Fluorescentes Verdes/metabolismo , Leishmania major/efectos de los fármacos , Leishmaniasis Cutánea/parasitología , Luciferasas/metabolismo , Animales , Evaluación Preclínica de Medicamentos/instrumentación , Femenino , Expresión Génica , Genes Reporteros , Proteínas Fluorescentes Verdes/genética , Humanos , Leishmania major/genética , Leishmania major/crecimiento & desarrollo , Leishmania major/fisiología , Luciferasas/genética , Ratones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA